Bloom Energy (BE) Stock Surges 5% Following Nancy Pelosi's Disclosure

Quick Summary

Table of Contents

Shares of Bloom Energy climbed 5% in Tuesday trading following the disclosure that Nancy Pelosi acquired 15,000 shares and 200 call options in late July.
Second-quarter revenue reached $1.07 billion, representing a 166% year-over-year increase, while earnings per share of $0.78 surpassed analyst expectations of $0.39.
The company elevated its 2026 full-year revenue outlook to a range of $3.9 billion to $4.2 billion, driven by artificial intelligence data center infrastructure needs.
Analyst consensus stands at “Moderate Buy” with a mean price target of $248.05, suggesting approximately 21% potential upside from current levels.
Key concerns include an elevated forward P/E ratio near 74, recent insider stock sales, and pending securities litigation regarding alleged China supply chain disclosures.

Shares of Bloom Energy began Tuesday’s session at $213.55, marking a gain from the previous closing price of $204.02, following congressional financial disclosure documents that revealed Nancy Pelosi’s household established a new stake in the fuel-cell manufacturer.

Bloom Energy Corporation, BE

By midday, the stock reached an intraday peak of $214.34, with trading volume exceeding 4 million shares.

Congressional filings made public on August 21 revealed two separate Bloom Energy Class A stock acquisitions executed on July 24 and July 28, comprising a total of 15,000 shares. The documentation additionally noted 200 call option contracts carrying a $100 strike price with a June 2027 expiration date.

According to the disclosure ranges mandated by congressional reporting requirements, the aggregate position value falls between approximately $4.25 million and $14.5 million.

These transactions represent Pelosi’s initial documented investment in Bloom Energy.

Pelosi’s investment activity attracts significant attention from retail market participants. A MarketWise survey conducted in July revealed that 34% of investors who replicate congressional trades monitor her transactions, ranking her just behind Warren Buffett at 35%. According to Quiver Quantitative tracking data, her portfolio has delivered cumulative gains of 965% since 2014, substantially outpacing the S&P 500’s 313% return over the same period.

The same disclosure documents showed Pelosi also acquired Intel shares and call options. Intel maintains a customer relationship with Bloom Energy, tying both investments to the broader AI infrastructure investment theme.

Impressive Q2 Earnings Contributed to Momentum

Pelosi’s disclosed position came on the heels of robust quarterly performance. Bloom reported second-quarter revenue of $1.07 billion, representing a 166% year-over-year surge and marking the company’s first time surpassing the $1 billion threshold in a single quarter. Earnings per share of $0.78 significantly exceeded the Wall Street consensus forecast of $0.39.

Company leadership increased its full-year 2026 outlook to a revenue range of $3.9 billion to $4.2 billion, with gross margin projections of 34% and earnings per share guidance between $2.55 and $2.85.

Analyst projections anticipate current-year revenue growth of approximately 103% to reach roughly $4.13 billion, with further expansion to more than $6.77 billion anticipated in 2026.

An expanded partnership agreement with Oracle, potentially supporting up to 2.8 gigawatts of fuel-cell infrastructure, was highlighted as a primary growth catalyst. Management indicated that its AI infrastructure customer base now encompasses nearly two dozen clients and approximately 250 MW of capacity beyond the Oracle partnership.

Valuation Considerations and Risk Factors

Despite positive momentum, Bloom’s current valuation metrics warrant scrutiny. The forward non-GAAP price-to-earnings multiple stands near 74, substantially exceeding the S&P 500’s approximate average of 20. Shares have retreated from a year-to-date peak approaching $350.

The Street consensus rating is “Moderate Buy” with a mean price objective of $248.05. Among 26 analysts providing coverage, three assign Strong Buy ratings, 10 recommend Buy, 12 suggest Hold, and one rates it Sell.

Recent insider selling activity presents an additional consideration for investors. Board member Jeffrey Immelt disposed of 30,000 shares on August 17 at an average execution price of $238.91. Insider Satish Chitoori sold 2,053 shares on August 14. Cumulative insider sales during the most recent quarter totaled approximately 144,000 shares valued at $38.5 million.

Active securities fraud litigation alleging the company provided misleading information regarding its China supply chain dependencies continues to progress, with a lead-plaintiff deadline established for September 28.

JPMorgan maintains an Overweight rating on the stock with a $314 price target.

✨ Limited Time Offer